Notices. DEPARTMENT OF HEALTH AND HUMAN SERVICES

443 words·~2 min read·/register/2016/11/29/2016-28625

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

BILLING CODE 4140-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Center for Advancing Translational Sciences; Notice of Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of meetings of the National Center for Advancing Translational Sciences. The meetings will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. *Name of Committee:* Cures Acceleration Network Review Board. *Date:* January 12, 2017. *Time:* 8:30 a.m. to 2:30 p.m. *Agenda:* Report from the Institute Director. *Place:* National Institutes of Health, Building 31, Conference Room 10, 31 Center Drive, Bethesda, MD 20892. *Contact Person:* Anna L.

Ramsey-Ewing, Ph.D., Executive Secretary, National Center for Advancing Translational Sciences, 1 Democracy Plaza, Room 1072, Bethesda, MD 20892, 301-435-0809, *anna.ramseyewing@nih.gov.* *Name of Committee:* National Center for Advancing Translational Sciences Advisory Council. *Date:* January 12, 2017. Open: 8:30 a.m. to 2:30 p.m. *Agenda:* Report from the Institute Director and other staff. *Place:* National Institutes of Health, Building 31, Conference Room 10, 31 Center Drive, Bethesda, MD 20892.

Closed: 3:00 p.m. to 4:30 p.m. *Agenda:* To review and evaluate grant applications. *Place:* National Institutes of Health, Building 31, Conference Room 10, 31 Center Drive, Bethesda, MD 20892. *Contact Person:* Anna L. Ramsey-Ewing, Ph.D., Executive Secretary, National Center for Advancing Translational Sciences, 1 Democracy Plaza, Room 1072, Bethesda, MD 20892, 301-435-0809, *anna.ramseyewing@nih.gov.* In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus.

All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver's license, or passport) and to state the purpose of their visit. (Catalogue of Federal Domestic Assistance Program Nos. 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.350, B—Cooperative Agreements; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS) Dated:

November 22, 2016. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016-28625 Filed 11-28-16; 8:45 am]